eli lilly gip/glp-1 What's Coming Next for GLP-1 and Metabolic Disease Treatment Eli Lilly's oral GLP-1 pill

People Going Blind From GLP-1: Risks, Evidence and Protection Recent reports have raised concerns about potential links between GLP-1 medications and vision problems, prompting questions about whether people are going blind from GLP-1 treatments

Scand J Clin Lab Invest Suppl

The results were impressive, with tirzepatide demonstrating a significant reduction in the apnea-hypopnea index, a measure of sleep apnea severity, compared to placebo

Physiology & Behavior

They run as an interconnected system

This may involve earlier use of combination therapies, personalized dose adjustments, and integration with digital health systems to monitor real-time glucose trends